Background: The authors write (line 27, page 4) "where type 16 accounts for more than half of all infections globally" (ref 4, Forman et al) . This reference does not say that and indeed HPV16 is the most frequent type but it is detected, the most, at 30% among women positive for HPV with normal cytology. So this sentence needs correction. Furthermore, the background is quite extended, and in my opinion it should be smaller.
Methods: 1) "Serotypes" (line 27, page 7) should be referred to as "genotypes". 2) (line 38, page 7) Regarding possibility (1), it should be mentioned clearly that cryotherapy is performed when there is a low-grade VIA or DC impression.
Results: It is mentioned that 50/56 positive women were HPV+ with self-sampling and 45/56 were positive with physician sampling. Since only these two kinds of samples were used how could the authors identify 56 women HPV+? Discussion: 1) Line 19, page 9. The authors state that the screen and treat strategy they proposed is cost-effective. This conclusion is not supported by the results presented in the study. 2) Line 40, page 9: The study is very small (n=250) to be able to assess HPV prevalence, and the sample cannot be representative since recruitment was done only from a particular centre. Moreover, the sample actually consists of two groups of women (HIV negative and HIV positive) which makes the denominator of prevalence even smaller for each group. 3) The authors state that they propose a screen and treat approach with HPV self-sampling followed by DC for HPV positive women, and they also suggest that the WHO guidelines are changed favouring colposcopy instead of VIA. Firstly, VIA is proposed only for low-resource settings (maybe Cambodia is one) because it is difficult to incorporate colposcopy and biopsy in such settings due to cost and non-adherence of women to the prevention strategy. Secondly, the study is very small in order to permit conclusions regarding optimal screening strategies and to suggest changes in the WHO guidelines.Third, it is definitely better to perform LEEP when there is a CIN2+ lesion instead of cryotherapy. But in order to do that one has to have either a high expertise in colposcopy or the option of histology on cervical biopsies. All these parameters are not in line with a low-resource setting as the one that the guidelines of WHO have been designed for. Therefore, the study is not powered to suggest a change of guidelines.
In general, the authors reach conclusions not supported by the presented results. The study is not a diagnostic accuracy study so one cannot draw conclusions on diagnostic accuracy, so the authors should not use terms as sensitivity and specificity. The study could be considered as a case-control study regarding differences between HIV positive and negative women, and a survey yielding results on self-sampling acceptability. Also it could be viewed as a feasibility (pilot) study, regarding the proposed screening strategy (self-sampling HPV + DC), requiring however, a large follow up study in order to draw conclusions on effectiveness and cost. 2. Related to the methods and indicated above, its' important to further define or describe how some of the procedures were performed. For example, more on how the specimens were collected and which tools or materials were used, how the expert colposcopists came to a conclusion of CIN1 vs CIN2+ on digital colposcopy images and so on in the methods. I understand some of this is in the full protocol but the key aspects of the procedures and data sources also need to be in the methods section. 3. I also have some few minor comments on spelling errors, inconsistent tenses and spacing between sentences that need to be reviewed. Plus, some sentences begin with abbreviations or digits that should be written in words and those should be corrected to make the manuscript better.
REVIEWER

VERSION 1 -AUTHOR RESPONSE
Reviewers 1 "Background: The authors write (line 27, page 4) "where type 16 accounts for more than half of all infections globally" (ref 4, Forman et al). This reference does not say that and indeed HPV16 is the most frequent type but it is detected, the most, at 30% among women positive for HPV with normal cytology. So this sentence needs correction."
We agree with this comment and have made the following change:
HPV also accounts for nearly all of the cases of cervical cancer. Infections of HPV strains 6, 11, 16, 18, 31, 33, 45, 52 , and 58 are responsible for 90% of cervical carcinoma." (Page 4, line 13-15) "Methods: 1) "Serotypes" (line 27, page 7) should be referred to as "genotypes""
This correction was made. (line 14, page 7)
"(line 38, page 7) Regarding possibility (1), it should be mentioned clearly that cryotherapy is performed when there is a low-grade VIA or DC impression."
This correction was made.
Cryotherapy performed the same day when either VIA or DC images were suspicious for CIN 1 lesions. (lines 23-24, pages 7)
Results: It is mentioned that 50/56 positive women were HPV+ with self-sampling and 45/56 were positive with physician sampling. Since only these two kinds of samples were used how could the authors identify 56 women HPV+?
We agree with this comment and have added the following to the discussion section of the paper:
One limitation of this study is that the careHPV system is less sensitive than both the Hybrid Capture 2 system and HPV-PCR. Previous studies have shown that the sensitivity of careHPV system to detect CIN2+ lesion is 88.1%. Since HPV-PCR was not performed on all specimens, we cannot give the exact prevalence of hrHPV in our patient population. (Page 12, Line 11-14)
"Discussion: 1) Line 19, page 9. The authors state that the screen and treat strategy they proposed is cost-effective. This conclusion is not supported by the results presented in the study."
We agree with this comment and have removed the term "cost-effective."
"2) Line 40, page 9: The study is very small (n=250) to be able to assess HPV prevalence, and the sample cannot be representative since recruitment was done only from a particular centre. Moreover, the sample actually consists of two groups of women (HIV negative and HIV positive) which makes the denominator of prevalence even smaller for each group."
We agree with this comment that this is too small a sample to assess prevalence and have removed the discussion of prevalence from the discussion section.
"
3) The authors state that they propose a screen and treat approach with HPV self-sampling followed by DC for HPV positive women, and they also suggest that the WHO guidelines are changed favouring colposcopy instead of VIA. Firstly, VIA is proposed only for low-resource settings (maybe Cambodia is one) because it is difficult to incorporate colposcopy and biopsy in such settings due to cost and non-adherence of women to the prevention strategy. Secondly, the study is very small in order to permit conclusions regarding optimal screening strategies and to suggest changes in the WHO guidelines.Third, it is definitely better to perform LEEP when there is a CIN2+ lesion instead of cryotherapy. But in order to do that one has to have either a high expertise in colposcopy or the option of histology on cervical biopsies. All these parameters are not in line with a low-resource setting as the one that the guidelines of WHO have been designed for. Therefore, the study is not powered to suggest a change of guidelines." In general, the authors reach conclusions not supported by the presented results. The study is not a diagnostic accuracy study so one cannot draw conclusions on diagnostic accuracy, so the authors should not use terms as sensitivity and specificity. The study could be considered as a case-control study regarding differences between HIV positive and negative women, and a survey yielding results on self-sampling acceptability. Also it could be viewed as a feasibility (pilot) study, regarding the proposed screening strategy (self-sampling HPV + DC), requiring however, a large follow up study in order to draw conclusions on effectiveness and cost."
We greatly appreciate this detailed comment and believe that the reviewer is correct. Specifically, we also agree that our study is best viewed as a pilot study and that our results need to be confirmed in much larger studies before WHO guidelines are changed. As such, we have changed the title of the paper to: In addition, we have added:
This pilot study was designed to explore new strategies for cervical cancer screening in Cambodian women. (page 8, lines 2-3)
The results of this pilot study might suggest potential modifications of the current cervical screening strategy that is currently being employed in Cambodia on a limited basis. (Page 10, line 10-11)
As such, given the new evidence put forth in our pilot study, we suggest that the WHO guidelines might be modified in countries with the necessary resources to favor digital colposcopy over VIA after HPV testing, if the results of our pilot study are confirmed in subsequent large-scale studies. ( Page 11, (17) (18) (19) (20) (21) Reviewer: 2 "Outcomes: I think the outcomes/ed points as well as other variables need to be clearly defined in the methods section. For example, the methods do not indicate the variables and the data sources. Perhaps more information is in the detailed protocol but more needs to be in the manuscript on the methods used."
We agree with this suggestion and have added the following to the methods section:
The specific variables being measured in this study include: 1) The percentage of Cambodian women who feel comfortable obtaining self-swabs for hrHPV.
2) The rate of hrHPV positivity in self-sampled swabs and clinician collected samples.
3) The rates of cervical dysplasia in HIV-positive and the HIVnegative Cambodian women. (Page 7, lines 27-31) "2. References: My particular comment is on citation 1 on the GLOBOCAN data where the 2012 report was used and yet we already have statistics for 2018. Please use those instead!"
The statistics and reference were updated "3. Limitations: The only limitation stated is that the results may not be applicable to women in rural Cambodia and I think it would be better to further elaborate on this mainly on the reasons this is so."
We agree with this comment and have added the following:
An additional limitation of this study is that the results may not be applicable to women in more rural regions of Cambodia. While patients were recruited from this study from both urban and rural settings, there are ethnic groups, especially from the more mountainous regions of Cambodia, not well represented in our study population. Potentially, women from these ethnicities might not be as comfortable self-swabbing as the women in our study. "1. The TM for the EVA system is not EVA but rather MobileODT and EVA should be stated in full as Enhanced Visual Assessment at initial use."
We contacted the company and both EVA and MobileODT are trademarked. We have added Enhanced Visual Assessment at initial use.
2. Related to the methods and indicated above, its' important to further define or describe how some of the procedures were performed. For example, more on how the specimens were collected and which tools or materials were used, how the expert colposcopists came to a conclusion of CIN1 vs CIN2+ on digital colposcopy images and so on in the methods. I understand some of this is in the full protocol but the key aspects of the procedures and data sources also need to be in the methods section.
We had originally omitted this information for brevity sake, but we have added:
Thin acetowhite lesions were considered positive and suspicious for CIN 1 lesions. Thick acetowhite lesions, lesions with mosaicism or punctation, or abnormal blood vessels were considered positive and suspicious of CIN 2+ lesions.
VERSION 2 -REVIEW
REVIEWER
Kimon Chatzistamatiou
Aristotle University of Thessaloniki, Greece REVIEW RETURNED 27-Nov-2018
GENERAL COMMENTS
Dear author, You have addressed adequately my comments regarding the 1st edition of the paper apart from one. It is not exactly clear to me how the hrHPV positivity was calculated. You mention that only two HPV tests were done on the 250 women participating in the study. From each woman two samples were taken and tested, a self-collected and a physician-collected one. According to the selfcollected samples 50 women were tested positive for hrHPV, and according to the physician-collected samples 45 women were tested positive for hrHPV. However, the overall results mention that 56 women were hrHPV positive. How is this possible? This would be possible only if you had a reference HPV test performed on all the women of the study population which could identify 56 women out of the 250. Otherwise, I can only imagine that selfsampling was positive for 50 women and negative for 6 additional women, who were tested positive with physician-sampling. At the same time 45 women were tested positive with physician sampling and 11 women tested negative for physician sampling and at the same time tested positive with self-sampling. The paper has been changed properly however, this result is fundamental and needs to be clarified in order for the reader to make sense. Thank you. It is not exactly clear to me how the hrHPV positivity was calculated. You mention that only two HPV tests were done on the 250 women participating in the study. From each woman two samples were taken and tested, a self-collected and a physician-collected one. According to the self-collected samples 50 women were tested positive for hrHPV, and according to the physician-collected samples 45 women were tested positive for hrHPV. However, the overall results mention that 56 women were hrHPV positive. How is this possible? This would be possible only if you had a reference HPV test performed on all the women of the study population which could identify 56 women out of the 250. Otherwise, I can only imagine that self-sampling was positive for 50 women and negative for 6 additional women, who were tested positive with physician-sampling. At the same time 45 women were tested positive with physician sampling and 11 women tested negative for physician sampling and at the same time tested positive with self-sampling.
VERSION 2 -AUTHOR RESPONSE
The paper has been changed properly however, this result is fundamental and needs to be clarified in order for the reader to make sense.
WE HAVE CLARIFIED THE RESULTS SECTION TO ADDRESS THIS.
"56 of the 250 (22·4%) women tested positive for high-risk HPV (hrHPV+). Of these 56 women, 39 tested positive in both their self-sampled specimen and physician obtained specimen. Eleven women were positive only with self-sampling, and 6 were only positive in the physician obtained specimens. Self-sampling identified 50/56 (89%) whereas physician obtained specimens only identified 45/56 (80%) p=0.174 NS.
VERSION 3 -REVIEW
REVIEWER
Kimon Chatzistamatiou Aristotle University of Thessaloniki, Thessaloniki, Greece REVIEW RETURNED 08-Jan-2019
GENERAL COMMENTS
All the issued raised have been addressed by the authors adequately.
